University of Groningenfounded in 1614  -  top 100 university
Close
Research Research database

JACC. Heart failure, 2213-1779

Journal

1 - 45 out of 45Page size: 50
  1. 2020
  2. Ezekowitz, J. A., O'Connor, C. M., Troughton, R. W., Alemayehu, W. G., Westerhout, C. M., Voors, A. A., Butler, J., Lam, C. S. P., Ponikowski, P., Emdin, M., Patel, M. J., Pieske, B., Roessig, L., Hernandez, A. F., & Armstrong, P. W. (2020). N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes. JACC. Heart failure, 8(11), 931-939. https://doi.org/10.1016/j.jchf.2020.08.008
  3. Gorter, T. M., van Woerden, G., Rienstra, M., Dickinson, M. G., Hummel, Y. M., Voors, A. A., Hoendermis, E. S., & van Veldhuisen, D. J. (2020). Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction. JACC. Heart failure, 8(8), 667-676. https://doi.org/10.1016/j.jchf.2020.06.003
  4. Nunez, J., Bayes-Genis, A., Revuelta-Lopez, E., ter Maaten, J. M., Minana, G., Barallat, J., Cserkoova, A., Bodi, V., Fernandez-Cisnal, A., Nunez, E., Sanchis, J., Lang, C., Ng, L. L., Metra, M., & Voors, A. A. (2020). Clinical Role of CA125 in Worsening Heart Failure A BIOSTAT-CHF Study Subanalysis. JACC. Heart failure, 8(5), 386-397. https://doi.org/10.1016/j.jchf.2019.12.005
  5. Cunningham, J. W., Vaduganathan, M., Claggett, B. L., Zile, M. R., Anand, I. S., Packer, M., Zannad, F., Lam, C. S. P., Janssens, S., Jhund, P. S., Kober, L., Rouleau, J., Shah, S. J., Chopra, V. K., Shi, V. C., Lefkowitz, M. P., Prescott, M. F., Pfeffer, M. A., McMurray, J. J., & Solomon, S. D. (2020). Effects of Sacubitril/Valsartan on N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Election Fraction. JACC. Heart failure, 8(5), 372-381. https://doi.org/10.1016/j.jchf.2020.03.002
  6. Cunningham, J. W., Ferreira, J. P., Deng, H., Anker, S. D., Byra, W. M., Cleland, J. G. F., Gheorghiade, M., Lam, C. S. P., La Police, D., Mehra, M. R., Neaton, J. D., Spiro, T. E., van Veldhuisen, D. J., Greenberg, B., & Zannad, F. (2020). Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial Insights From COMMANDER HF. JACC. Heart failure, 8(5), 359-368. https://doi.org/10.1016/j.jchf.2019.12.009
  7. Voors, A. A. (2020). Should Enrichment With Natriuretic Peptide Levels Be Mandatory in Global Clinical Trials? JACC. Heart failure, 8(5), 369-371. https://doi.org/10.1016/j.jchf.2020.01.007
  8. Tromp, J., Voors, A. A., Sharma, A., Ferreira, J. P., Ouwerkerk, W., Hillege, H. L., Gomez, K. A., Dickstein, K., Anker, S. D., Metra, M., Lang, C. C., Ng, L. L., van der Harst, P., van Veldhuisen, D. J., van Der Meer, P., Lam, C. S. P., Zannad, F., & Sama, I. E. (2020). Distinct Pathological Pathways in Patients With Heart Failure and Diabetes. JACC. Heart failure, 8(3), 234-242. https://doi.org/10.1016/j.jchf.2019.11.005
  9. Li, J., Woodward, M., Perkovic, V., Figtree, G. A., Heerspink, H. J. L., Mahaffey, K. W., de Zeeuw, D., Vercruysse, F., Shaw, W., Matthews, D. R., & Neal, B. (2020). Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes. JACC. Heart failure, 8(1), 57-66. https://doi.org/10.1016/j.jchf.2019.08.004
  10. 2019
  11. Beusekamp, J. C., Tromp, J., Cleland, J. G. F., Givertz, M. M., Metra, M., O'Connor, C. M., Teerlink, J. R., Ponikowski, P., Ouwerkerk, W., van Veldhuisen, D. J., Voors, A. A., & van der Meer, P. (2019). Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. JACC. Heart failure, 7(11), 970-979. https://doi.org/10.1016/j.jchf.2019.07.010
  12. PARAGON-HF Investigators, Chandra, A., Vaduganathan, M., Lewis, E. F., Claggett, B. L., Rizkala, A. R., Wang, W., Lefkowitz, M. P., Shi, V. C., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., ... Solomon, S. D. (2019). Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial. JACC. Heart failure, 7(10), 862-874. https://doi.org/10.1016/j.jchf.2019.05.015
  13. GENETIC-AF Trial Investigators, Piccini, J. P., Abraham, W. T., Dufton, C., Carroll, I. A., Healey, J. S., van Veldhuisen, D. J., Sauer, W. H., Anand, I. S., White, M., Wilton, S. B., Aleong, R., Rienstra, M., Krueger, S. K., Ayala-Paredes, F., Khaykin, Y., Merkely, B., Miloradovic, V., Wranicz, J. K., ... Connolly, S. J. (2019). Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial. JACC. Heart failure, 7(7), 586-598. https://doi.org/10.1016/j.jchf.2019.04.004
  14. ter Maaten, J. M., & Voors, A. A. (2019). Time to Revisit the Value of Urine Collections in Heart Failure. JACC. Heart failure, 7(5), 392-393. https://doi.org/10.1016/j.jchf.2019.01.015
  15. Martens, P., Dupont, M., Verbrugge, F. H., Damman, K., Degryse, N., Nijst, P., Reynders, C., Penders, J., Tang, W. H. W., Testani, J., & Mullens, W. (2019). Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure. JACC. Heart failure, 7(5), 404-414. https://doi.org/10.1016/j.jchf.2019.02.011
  16. Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., Kitzman, D. W., Lam, C. S. P., van Veldhuisen, D. J., Ponikowski, P., Petrie, M. C., Hassager, C., Moller, J. E., & Gustafsson, F. (2019). Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction. JACC. Heart failure, 7(4), 321-332. https://doi.org/10.1016/j.jchf.2019.01.006
  17. Savarese, G., Vedin, O., D'Amario, D., Uijl, A., Dahlstrom, U., Rosano, G., Lam, C. S. P., & Lund, L. H. (2019). Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure. JACC. Heart failure, 7(4), 306-317. https://doi.org/10.1016/j.jchf.2018.11.019
  18. Beldhuis, I. E., Myhre, P. L., Claggett, B., Damman, K., Fang, J. C., Lewis, E. F., O'Meara, E., Pitt, B., Shah, S. J., Voors, A. A., Pfeffer, M. A., Solomon, S. D., & Desai, A. S. (2019). Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease. JACC. Heart failure, 7(1), 25-32. https://doi.org/10.1016/j.jchf.2018.10.017
  19. 2018
  20. Lam, C. S. P., & Chandramouli, C. (2018). Fat, Female, Fatigued Features of the Obese HFpEF Phenotype. JACC. Heart failure, 6(8), 710-713. https://doi.org/10.1016/j.jchf.2018.06.006
  21. Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., Gardin, J. M., Hillege, H. L., Ji, F., Kop, W. J., Lau, E. S., Lee, D. S., Sadreyev, R., van Gilst, W. H., Wang, T. J., ... Ho, J. E. (2018). The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF. JACC. Heart failure, 6(8), 701-709. https://doi.org/10.1016/j.jchf.2018.05.018
  22. Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Swedberg, K., Zile, M. R., Packer, M., Desai, A. S., Solomon, S. D., & McMurray, J. J. V. (2018). Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC. Heart failure, 6(6), 489-498. https://doi.org/10.1016/j.jchf.2018.02.004
  23. Cerbin, L. P., Ambrosy, A. P., Greene, S. J., Armstrong, P. W., Butler, J., Coles, A., DeVore, A. D., Ezekowitz, J. A., Hernandez, A. F., Metra, M., Starling, R. C., Tang, W., Teerlink, J. R., Voors, A. A., Wu, A., O'Connor, C. M., & Mentz, R. J. (2018). Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. JACC. Heart failure, 6(4), 298-307. https://doi.org/10.1016/j.jchf.2018.01.018
  24. Beverborg, N. G., van Veldhuisen, D. J., & van der Meer, P. (2018). Anemia in Heart Failure Still Relevant? JACC. Heart failure, 6(3), 201-208. https://doi.org/10.1016/j.jchf.2017.08.023
  25. Voors, A. A. (2018). Sense and Sensibility of the Use of NT-proBNP for Eligibility in Clinical Trials. JACC. Heart failure, 6(3), 257-259. https://doi.org/10.1016/j.jchf.2018.01.003
  26. Armstrong, P. W., Roessig, L., Patel, M. J., Anstrom, K. J., Butler, J., Voors, A. A., Lam, C. S. P., Ponikowski, P., Temple, T., Pieske, B., Ezekowitz, J., Hernandez, A. F., Koglin, J., & O'Connor, C. M. (2018). A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator The VICTORIA Trial. JACC. Heart failure, 6(2), 96-104. https://doi.org/10.1016/j.jchf.2017.08.013
  27. 2017
  28. Damman, K., & Voors, A. A. (2017). The Fastest Way to the Failing Heart Is Through the Kidneys. JACC. Heart failure, 5(9), 682-683. https://doi.org/10.1016/j.jchf.2017.06.001
  29. Solomon, S. D., Rizkala, A. R., Gong, J., Wang, W., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., Redfield, M. M., Rouleau, J. L., Van Veldhuisen, D. J., Zannad, F., Zile, M. R., Desai, A. S., Shi, V. C., ... McMurray, J. J. V. (2017). Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial. JACC. Heart failure, 5(7), 471-482. https://doi.org/10.1016/j.jchf.2017.04.013
  30. Tromp, J., Khan, M. A. F., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G. F., Givertz, M. M., Bloomfield, D. M., Van Veldhuisen, D. J., Hillege, H. L., Voors, A. A., & van der Meer, P. (2017). Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. JACC. Heart failure, 5(7), 507-517. https://doi.org/10.1016/j.jchf.2017.04.007
  31. Mulder, B. A., Van Veldhuisen, D. J., & Rienstra, M. (2017). Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation. JACC. Heart failure, 5(6), 466-467. https://doi.org/10.1016/j.jchf.2017.03.010
  32. O'Connor, C. M., & van Veldhuisen, D. J. (2017). Data Sharing From the Editors' Perspective Our Hope With Limitations. JACC. Heart failure, 5(4), 314-315. https://doi.org/10.1016/j.jchf.2017.02.007
  33. Aimo, A., Vergaro, G., Ripoli, A., Bayes-Genis, A., Pascual Figal, D. A., de Boer, R. A., Lassus, J., Mebazaa, A., Gayat, E., Breidthardt, T., Sabti, Z., Mueller, C., Brunner-La Rocca, H-P., Tang, W. H. W., Grodin, J. L., Zhang, Y., Bettencourt, P., Maisel, A. S., Passino, C., ... Emdin, M. (2017). Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure. JACC. Heart failure, 5(4), 287-296. https://doi.org/10.1016/j.jchf.2016.12.016
  34. Lam, C. S. P., Rienstra, M., Tay, W-T., Liu, L. C. Y., Hummel, Y. M., van der Meer, P., de Boer, R. A., Van Gelder, I. C., van Veldhuisen, D. J., Voors, A. A., & Hoendermis, E. S. (2017). Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. JACC. Heart failure, 5(2), 92-98. https://doi.org/10.1016/j.jchf.2016.10.005
  35. Ambrosy, A. P., Cerbin, L. P., Armstrong, P. W., Butler, J., Coles, A., DeVore, A. D., Dunlap, M. E., Ezekowitz, J. A., Felker, G. M., Fudim, M., Greene, S. J., Hernandez, A. F., O'Connor, C. M., Schulte, P., Starling, R. C., Teerlink, J. R., Voors, A. A., & Mentz, R. J. (2017). Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial. JACC. Heart failure, 5(1), 1-13. https://doi.org/10.1016/j.jchf.2016.09.012
  36. 2016
  37. Meems, L. M. G., Brouwers, F. P., Joosten, M. M., Lambers Heerspink, H. J., de Zeeuw, D., Bakker, S. J. L., Gansevoort, R. T., van Gilst, W. H., van der Harst, P., & de Boer, R. A. (2016). Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study. JACC. Heart failure, 3(3), 189-197. https://doi.org/10.1002/ehf2.12089
  38. Testani, J. M., & ter Maaten, J. M. (2016). Decongestion in Acute Heart Failure Does the End Justify the Means? JACC. Heart failure, 4(7), 589-590. https://doi.org/10.1016/j.jchf.2016.03.024
  39. Pang, P. S., Teerlink, J. R., Voors, A. A., Ponikowski, P., Greenberg, B. H., Filippatos, G., Felker, G. M., Davison, B. A., Cotter, G., Kriger, J., Prescott, M. F., Hua, T. A., Severin, T., & Metra, M. (2016). Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes An Exploratory Analysis From the RELAX-AHF Trial. JACC. Heart failure, 4(7), 591-599. https://doi.org/10.1016/j.jchf.2016.02.009
  40. Zipes, D. P., Neuzil, P., Theres, H., Caraway, D., Mann, D. L., Mannheimer, C., Van Buren, P., Linde, C., Linderoth, B., Kueffer, F., Sarazin, S. A., DeJongste, M. J. L., & DEFEAT-HF Trial Investigators (2016). Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure The DEFEAT-HF Study. JACC. Heart failure, 4(2), 129-136. https://doi.org/10.1016/j.jchf.2015.10.006
  41. Tang, W. H. W., Wu, Y., Grodin, J. L., Hsu, A. P., Hernandez, A. F., Butler, J., Metra, M., Voors, A. A., Felker, G. M., Troughton, R. W., Mills, R. M., McMurray, J. J., Armstrong, P. W., O'Connor, C. M., & Starling, R. C. (2016). Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. JACC. Heart failure, 4(1), 68-77. https://doi.org/10.1016/j.jchf.2015.07.015
  42. 2015
  43. Voors, A. A., & ter Maaten, J. M. (2015). Tackling Early Heart Failure Deaths and Readmissions by Estimating Congestion. JACC. Heart failure, 3(11), 894-895. https://doi.org/10.1016/j.jchf.2015.06.013
  44. Grodin, J. L., Perez, A. L., Wu, Y., Hernandez, A. F., Butler, J., Metra, M., Felker, G. M., Voors, A. A., McMurray, J. J., Armstrong, P. W., Califf, R. M., Starling, R. C., O'Connor, C. M., & Tang, W. H. W. (2015). Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). JACC. Heart failure, 3(10), 777-785. https://doi.org/10.1016/j.jchf.2015.06.006
  45. Davison, B. A., Metra, M., Cotter, G., Massie, B. M., Cleland, J. G. F., Dittrich, H. C., Edwards, C., Filippatos, G., Givertz, M. M., Greenberg, B., Ponikowski, P., Voors, A. A., O'Connor, C. M., Teerlink, J. R., & PROTECT & RELAX-AHF Executive Comm (2015). Worsening Heart Failure Following Admission for Acute Heart Failure A Pooled Analysis of the PROTECT and RELAX-AHF Studies. JACC. Heart failure, 3(5), 395-403. https://doi.org/10.1016/j.jchf.2015.01.007
  46. Felker, G. M., Butler, J., Collins, S. P., Cotter, G., Davison, B. A., Ezekowitz, J. A., Filippatos, G., Levy, P. D., Metra, M., Ponikowski, P., Soergel, D. G., Teerlink, J. R., Violin, J. D., Voors, A. A., & Pang, P. S. (2015). Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor Rationale and Design of the BLAST-AHF Study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure). JACC. Heart failure, 3(3), 193-201. https://doi.org/10.1016/j.jchf.2014.09.008
  47. Tang, W. H. W., Dupont, M., Hernandez, A. F., Voors, A. A., Hsu, A. P., Felker, G. M., Butler, J., Metra, M., Anker, S. D., Troughton, R. W., Gottlieb, S. S., McMurray, J. J., Armstrong, P. W., Massie, B. M., Califf, R. M., O'Connor, C. M., & Starling, R. C. (2015). Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial. JACC. Heart failure, 3(1), 40-49. https://doi.org/10.1016/j.jchf.2014.06.014
  48. 2013
  49. Damman, K., Masson, S., Hillege, H. L., Voors, A. A., van Veldhuisen, D. J., Rossignol, P., Proietti, G., Barbuzzi, S., Nicolosi, G. L., Tavazzi, L., Maggioni, A. P., & Latini, R. (2013). Tubular Damage and Worsening Renal Function in Chronic Heart Failure. JACC. Heart failure, 1(5), 417-424. https://doi.org/10.1016/j.jchf.2013.05.007
  50. de Boer, R. A., Cao, Q., Postmus, D., Damman, K., Voors, A. A., Jaarsma, T., van Veldhuisen, D. J., Arnold, W. D., Hillege, H. L., & Sillje, H. H. W. (2013). The WAP Four-Disulfide Core Domain Protein HE4: A Novel Biomarker for Heart Failure. JACC. Heart failure, 1(2), 164-169. https://doi.org/10.1016/j.jchf.2012.11.005
  51. Rienstra, M., Damman, K., Mulder, B. A., Van Gelder, I. C., McMurray, J. J. V., & Van Veldhuisen, D. J. (2013). Beta-Blockers and Outcome in Heart Failure and Atrial Fibrillation A Meta-Analysis: a meta-analysis. JACC. Heart failure, 1(1), 21-28. https://doi.org/10.1016/j.jchf.2012.09.002
  52. Sanders-van Wijk, S., van Asselt, A. D. I., Rickli, H., Estlinbaum, W., Erne, P., Rickenbacher, P., Vuillomenet, A., Peter, M., Pfisterer, M. E., Brunner-La Rocca, H-P., & TIME-CHF Investigators (2013). Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure). JACC. Heart failure, 1(1), 64-71. https://doi.org/10.1016/j.jchf.2012.08.002

ID: 14240803

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube